| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 07/19/2000 | EP1020184A1 Sustained release tablets containing bupropion hydrochloride |
| 07/19/2000 | EP1020183A2 Analgesic composition with controlled release |
| 07/19/2000 | EP1020182A2 A two-layer pharmaceutical tablet comprising an nsaid and misoprostol |
| 07/19/2000 | EP1020181A1 Process for producing pellets with a pharmaceutical agent content of up to 90% w/w |
| 07/19/2000 | EP1020180A2 Biocompatible, injectable aqueous solution for use in ultrasound energy assisted surgery |
| 07/19/2000 | EP1020179A2 Peptide derivatives or pharmaceutically acceptable salts thereof, method for producing the same, use of said derivatives and pharmaceutical composition |
| 07/19/2000 | EP1020177A1 Multilayered soft capsule for eliminating foul breath and process for producing the same |
| 07/19/2000 | EP1019446A1 Degradable poly(ethylene glycol) hydrogels with controlled half-life and precursors therefor |
| 07/19/2000 | EP1019417A1 Phospholipid analogue compounds |
| 07/19/2000 | EP1019409A1 Poly(adp-ribose) polymerase ("parp") inhibitors, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage |
| 07/19/2000 | EP1019361A1 Polyfunctional cationic cytofectins, formulations and methods for generating active cytofectin:polynucleotide transfection complexes |
| 07/19/2000 | EP1019107A1 Drug release stent coating process |
| 07/19/2000 | EP1019105A1 Polar, lipophilic pressure-sensitive adhesive compositions and medical devices using same |
| 07/19/2000 | EP1019096A2 Bioresorbable compositions for implantable prostheses |
| 07/19/2000 | EP1019078A1 Use of cartilage oligomeric matrix protein for the treatment of rheumatoid arthritis |
| 07/19/2000 | EP1019073A1 Apolipoprotein a-i agonists and their use to treat dyslipidemic disorders |
| 07/19/2000 | EP1019071A2 Random peptides that bind to gastro-intestinal tract (git) transport receptors and related methods |
| 07/19/2000 | EP1019068A1 Therapeutic formulations containing venom or venom anti-serum either alone or in combination for the therapeutic prophylaxis and therapy of neoplasms |
| 07/19/2000 | EP1019065A1 Multiple target hybridizing nucleic acids, their preparation, compositions, formulation, kits and applications |
| 07/19/2000 | EP1019064A1 Inhibition of cell-cell binding by lipid assemblies |
| 07/19/2000 | EP1019061A1 Urease-responsive delivery systems for diagnostic and therapeutic applications |
| 07/19/2000 | EP1019058A1 Pharmaceutical suspension comprising nevirapine hemihydrate |
| 07/19/2000 | EP1019053A1 Amorphous paroxetine composition |
| 07/19/2000 | EP1019049A1 Methods and compositions for treating and/or preventing non-insulin dependent diabetes mellitus (niddm) using specific retinoid compounds |
| 07/19/2000 | EP1019039A1 Compressed nitroglycerin tablet and its method of manufacture |
| 07/19/2000 | EP1019038A1 Pharmaceutical composition for the treatment of inflammatory bowel disease and irritable bowel syndrome |
| 07/19/2000 | EP1019037A1 Medicament containing delta-aminolevulinic acid |
| 07/19/2000 | EP1019033A1 New formulation for inhalation having a poured bulk density of from 0.28 to 0.38 g/ml, comprising budesonide |
| 07/19/2000 | EP1019032A1 Method for preventing the misuse of a transdermal therapeutic system |
| 07/19/2000 | EP1019031A1 Biodegradable macromers for the controlled release of biologically active substances |
| 07/19/2000 | EP1019030A1 Method for making a multi-stage drug delivery system |
| 07/19/2000 | EP1019029A1 Monolithic system containing one or more drugs, consisting of three layers with different release mechanisms |
| 07/19/2000 | EP1019027A1 Implantable collagen-containing putty material |
| 07/19/2000 | EP1019026A2 Multilamellar coalescence vesicles (mlcv) containing biologically active compounds |
| 07/19/2000 | EP1019025A1 Peptide/lipid complex formation by co-lyophilization |
| 07/19/2000 | EP1019024A1 Aerosol ointment compositions and method of manufacture |
| 07/19/2000 | EP1019023A1 Stabilized preparations for use in nebulizers |
| 07/19/2000 | EP1019022A1 Perforated microparticles and methods of use |
| 07/19/2000 | EP1019021A1 Stabilized preparations for use in metered dose inhalers |
| 07/19/2000 | EP1019020A1 Stabilized bioactive preparations and methods of use |
| 07/19/2000 | EP1019019A1 Buccal, polar and non-polar spray or capsule |
| 07/19/2000 | EP1019010A1 Apolipoprotein a-i agonists and their use to treat dyslipidemic disorders |
| 07/19/2000 | EP1018880A1 2-methyl-thieno-benzodiazepine formulation |
| 07/19/2000 | EP0835102A4 Controlled release formulation having a preformed passageway |
| 07/19/2000 | EP0831784A4 Fragrances and flavorants |
| 07/19/2000 | EP0777495B1 Stable, aqueous alfa interferon solution formulations |
| 07/19/2000 | EP0706373B1 Liposome encapsulated taxol and a method of using the same |
| 07/19/2000 | EP0666845B1 Method for purifying beta-carotene |
| 07/19/2000 | EP0666762B1 Process for making lipid conjugates |
| 07/19/2000 | EP0661966B1 Ulcer prevention and treatment composition and method |
| 07/19/2000 | EP0389570B2 High integrity liposomes and method of preration and use |
| 07/19/2000 | CN1260878A Method and industrial process for determining dose-level characteristics of multiple unit system |
| 07/19/2000 | CN1260774A Method for producing medicines containing HMG-CoA-reductase inhibitors |
| 07/19/2000 | CN1260724A Nanoscale particles having iron oxide-containing core enveloped by at least two shells |
| 07/19/2000 | CN1260721A Use of cartilage oligeomeric matrix protein for treatment of rheumatoid |
| 07/19/2000 | CN1260714A Controlled release pharmaceutical preparation with ACE inhibitor as active agent |
| 07/19/2000 | CN1260713A Proliposome powders for inhalation stabilised by tocopherol |
| 07/19/2000 | CN1260712A Aerosols |
| 07/19/2000 | CN1260703A Drug delivery device and method for treating viral and microbial infections and wasting syndromes |
| 07/19/2000 | CN1260199A Multifunction quick-effect health medicinal plaster |
| 07/19/2000 | CN1260198A External-applied Chinese herbal medicine plaster for treating hepatitis B preparation method |
| 07/19/2000 | CN1260189A Application of radix scutellariae stem and leaf to pharmaceutical industry |
| 07/19/2000 | CN1260184A Oral preparation of traditional Chinese medicine medicated composition for treating psoriasis and its preparation method |
| 07/19/2000 | CN1260183A Cactus granule preparation and its preparation method |
| 07/19/2000 | CN1260177A Oral liquor of cytidine disphosphate choline and its preparation method |
| 07/19/2000 | CN1260174A Liquid preparation containing norfloxacin and metronidazole |
| 07/19/2000 | CN1260172A Dextro-betoprofen preparation |
| 07/19/2000 | CN1054545C Contrast media and use thereof |
| 07/19/2000 | CN1054543C Composition for sustained and controlled release of medicamentous substances and process for preparing same |
| 07/19/2000 | CN1054537C Medicine for treating centripetalis obesity |
| 07/19/2000 | CN1054533C Anti-inflammatory and pain-relieving capsule |
| 07/19/2000 | CN1054531C Yunnan-Baiyao aerosol and preparing method |
| 07/19/2000 | CN1054529C Slow-release adhesive film for treating caronary heart disease and preparation method thereof |
| 07/19/2000 | CN1054527C Longshe instant powder for recovering one's health and preparation method |
| 07/19/2000 | CN1054522C Sichuan aconite root analgesic soft extract |
| 07/19/2000 | CN1054513C Method for production of frozen dry extracts of sheep embryo |
| 07/19/2000 | CN1054510C Stable solution of rebeccamycin analog and preparation thereof |
| 07/19/2000 | CN1054508C Method for preparing pharmaceutical composition |
| 07/19/2000 | CN1054507C Preparation method for medicinal composition for treatment of vaginal infections |
| 07/18/2000 | US6090958 N-(8-carboxyoctyl)-o-hydroxybenzamide and salts |
| 07/18/2000 | US6090955 Liposome-encapsulated taxol, its preparation and its use |
| 07/18/2000 | US6090925 Macromolecular microparticles and methods of production and use |
| 07/18/2000 | US6090844 Pharmaceutical injection solution containing taxol |
| 07/18/2000 | US6090830 Controlled release compositions and methods for the treatment of hyperlipidemia |
| 07/18/2000 | US6090827 Pharmaceutical formulation of omeprazole |
| 07/18/2000 | US6090800 Reaction product containing dexamethasone |
| 07/18/2000 | US6090793 Non-mitogenic substance, its preparation and use |
| 07/18/2000 | US6090792 Maltose-trehalose converting enzyme, and preparation and uses thereof |
| 07/18/2000 | US6090790 Gene delivery by microneedle injection |
| 07/18/2000 | US6090732 Zinc-doped tricalcium phosphate ceramic material |
| 07/18/2000 | US6090412 Solid drug |
| 07/18/2000 | US6090411 Monolithic tablet for controlled drug release |
| 07/18/2000 | US6090410 Dry mix formulation for bisphosphonic acids |
| 07/18/2000 | US6090407 Administering anticancer drug to respiratory system |
| 07/18/2000 | US6090406 Potentiation of immune responses with liposomal adjuvants |
| 07/18/2000 | US6090405 Multilayer; backing layer and pressure sensitive adhesive |
| 07/18/2000 | US6090404 Sustained release patch |
| 07/18/2000 | US6090403 Skin patch |
| 07/18/2000 | US6090401 Stable foam composition |
| 07/18/2000 | US6090397 In situ film forming; wound healing agent |